NCCN Foundation awards leading young investigators advancing cancer research

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The National Comprehensive Cancer Network and the NCCN Foundation announced five new recipients for the 10th annual NCCN Foundation Young Investigator Awards Program.

The honorees will receive up to $150,000 in funding to study ways to improve care and help find cures for people with breast, colorectal, pancreatic, and small cell lung cancer, as well as pediatric acute myeloid leukemia. The NCCN Oncology Research Program managed the selection process and will oversee the projects, which will each extend for the next two years.

The 2020 NCCN Foundation YIA recipients are:

  • Agnieszka Czechowicz, assistant professor of pediatrics, Stanford University School of Medicine: “Development of anti-hKIT Chimeric Antigen Receptor T-Cells as a Dual Hematopoietic Stem Cell Transplantation Conditioning and Immunotherapeutic Agent for Cure of Pediatric Acute Myeloid Leukemia.”

  • Wade T. Iams, assistant professor of medicine, Vanderbilt University Medical Center: “Quantifying Minimal Residual Disease in Patients with Small Cell Lung Cancer.”

  • Shivan Mehta, assistant professor of medicine, University of Pennsylvania: “Choice Architecture and Mailed Colorectal Cancer Screening Outreach in a Community Health Setting.”

  • Mustafa Raoof, assistant clinical professor, City of Hope Beckman Research Institute: “Targeting Transcription-Replication Conflicts in KRAS-driven Pancreatic Cancer.”

  • Jennifer Y. Sheng, assistant professor in oncology, Johns Hopkins University School of Medicine: “An Adaptive Nutrition and Exercise Weight loss (A-NEW) Study for Breast Cancer Survivors.”

Table of Contents

YOU MAY BE INTERESTED IN

Candace S. Johnson leads America’s oldest cancer research center and Jonathan W. Friedberg leads the newest NCI-designated center. Their catchment areas are contiguous, their faculty and staff members collaborate often, and together their institutions embody the culture of NCI-designated cancer centers. 

In the first meeting of the National Cancer Advisory Board since the inauguration of President Donald Trump, NCI Principal Deputy Director Douglas R. Lowy addressed many of the burning questions the oncology field has for the institute. On indirect costs: NCI will continue to use previously negotiated and approved indirect cost rates, with the exception...

The Cancer Letter staff were finalists for nine 2025 Dateline Awards from the Washington, D.C. Chapter of the Society of Professional Journalists—seven for journalism; two for design—and won first place for four. The Cancer Letter’s entries recognized by SPJ include investigative journalism, series, breaking news, features, photojournalism, commentary, illustration, and front page design. This is...

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login